Martin Shkreli Reveals How He Made His First $100 Million (#445)
About this video
Sam and Shaan interview Martin Shkreli, the controversial pharmaceutical executive, who discusses his path to making his first millions through drug development rather than hedge fund management, explains his perspective on drug pricing through the lens of utility theory and insurance coverage, and previews his new AI-focused startup. Shkreli recounts his early career under Jim Cramer, founding Retrophin and discovering assets through PubMed research, and addresses common criticisms about his pricing decisions by questioning whether patients actually lost access to medications.
Key takeaways
- Martin made his first significant wealth (~$25M) through founding Retrophin, a pharmaceutical company built around a rare disease drug asset, not through his hedge fund work, which he describes as psychologically difficult and ultimately unprofitable
- Martin’s pricing philosophy is grounded in utility theory—pricing drugs based on the cost of alternative care rather than production costs—and he argues that zero patients lost access to his drug after price increases because insurance covered it and it represented <0.1% of insurer budgets
- Martin attributes much of the criticism against him to public unfamiliarity with pharmaceutical economics and industry practices, using the Socratic method to expose how little critics know about pricing, insurance dynamics, and the risk-adjusted returns needed to justify drug development investment
- Healthcare demand is uniquely inelastic compared to other goods because people will sacrifice almost anything for marginal health gains, which Martin believes justifies high pharmaceutical prices and explains why healthcare spending will continue rising as a share of GDP
- Martin criticizes ‘vanilla’ corporate executives who suppress their personalities to avoid controversy, arguing this stifles innovation, though he acknowledges his own combative communication style may have contributed to his legal troubles
Episode details: published April 20, 2023 · 389K views · 1:42:17 long. Summary written by Self Growth Videos from the episode itself. The business ideas, figures and results discussed are the hosts’ and guests’ own claims, shared as brainstorming and entertainment — not verified facts and not investment advice.
← Previous: Scott Harrison: From Nightclub Promoter to Charity Water Founder (#443) · Next: I Got My Own Netflix Show… Here’s How | Ramit Sethi (#446) →
All My First Million videos · My First Million profile · My First Million (official site)
You Might Also Enjoy

My First Million — Sam Parr & Shaan Puri Brainstorm Businesses
Explore →
We watched the Elizabeth Holmes doc (and honestly, WTF)
Explore →
How he beat the S&P 500 for 11 years doing (almost) nothing
Explore →
You can’t help but print money if you have these 6 traits
Explore →
Sam was offered $800K for access to all of his Hampton data.
Explore →